Skip to main content
Annals of Intensive Care
Fig. 2 | Annals of Intensive Care

Fig. 2

From: Effects of 12 mg vs. 6 mg dexamethasone on thromboembolism and bleeding in patients with critical COVID-19 - a post hoc analysis of the randomized, blinded COVID STEROID 2 trial

Fig. 2

Kaplan–Meier curves of outcomes during ICU stay according to dose of dexamethasone. Kaplan–Meier curves of A Death or Thromboembolism B Thromboembolism, and C Major bleeding events among 354 patients with critical COVID-19 by dose of dexamethasone. Thromboembolism in A and B defined as myocardial infarction, pulmonary embolism/thrombosis, deep vein thrombosis, ischemic stroke or other thromboembolic events. Major bleeding in C defined as a bleeding requiring transfusion of at least two units of red blood cells, an intracranial bleeding, and or a bleeding requiring a major therapeutic intervention

Back to article page